# ALPLA

> ALPLA is a VC fund in Hard backing Chemical, Biotechnology and Pharmaceutical. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Hard, Austria
- Total investments: 1
- Last investment: May 2014
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/110410
- X (Twitter): https://www.twitter.com/alplapackaging
- Website: https://www.alpla.com

ALPLA is a VC fund in Hard focused on Chemical and Biotechnology. ALPLA is packaging systems, bottles, caps and injection-moulded parts.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Chemical | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |
| Renewable Energy | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Avantium | Avantium is a leading technology company specialized in advanced high-throughput R&D for applications in the energy, chemicals and pharmaceutical industries. The company's headquarters and laboratories are located in Amsterdam, in the Netherlands.Avantium's proprietary high-throughput technology enables a faster and morecost-effective development of new and improved products and production processes. Using its unique rational approach towards the design of experiments and data analysis, Avantium is capable of accomplishing innovations with superior success rate. Avantium has demonstrated the validity and commercial viability of its technology by successfully providing research services and tools to more than 70 companies worldwide, including many industry leaders. The company's mission is to increase the success rate and economics of product and process development.Building on its expertise and track record in the energy, chemicals and pharmaceutical industries, Avantium focuses on developing products in two fields:new biofuels and bio-based chemicals, and new crystal forms of marketed drugs under patent.Avantium's strategy is to progress its development programs and exploit the commercial value of its expanding patent portfolio by securing value-adding partnerships during the coming years. Avantium seeks continuous expansion of its profitable services and tools business.Avantium has assembled a team of highly educated professionals who are experts in catalysis, crystallography, organic chemistry, engineering of robotic systems, process engineering, statistics, cheminformatics and software development. Its teams collaborate closely with partner R&D organizations. | $42.1M | Series G | May 22, 2014 |  |

1 of 1 investments shown.

## Co-investors
- [Aescap Venture](https://shizune.co/investors/profile/aescap-venture) — VC Fund, 1 deal together
- [Aster](https://shizune.co/investors/profile/aster-capital) — VC Fund, 1 deal together
- [Capricorn Partners](https://shizune.co/investors/profile/capricorn-partners) — VC Fund, 1 deal together
- [DANONE](https://shizune.co/investors/profile/danone) — VC Fund, 1 deal together
- De Hoge Dennen Capital — VC Fund, 1 deal together
- ING Corporate Investments — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [ALSTIN Family GmbH](https://shizune.co/investors/profile/alstin-family-gmbh) — VC Fund
- [Benjamin Kahn](https://shizune.co/investors/profile/benjamin-kahn) — Angel Investor
- [GPI Capital](https://shizune.co/investors/profile/gpi-capital) — VC Fund

## FAQ

### What does ALPLA invest in?

ALPLA invests primarily in Chemical, Biotechnology and Pharmaceutical startups, most often at Series G stage. Most of the 1 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did ALPLA last invest?

The most recent investment recorded for ALPLA closed in May 2014. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co